Powder: -20°C for 3 years | In solvent: -80°C for 1 year
RORγt Inverse agonist 8 is a potent, selective, orally bioavailable RORγt inverse agonist(human RORγt-LBD with an IC50 of 19 nM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,670.00 | |
50 mg | 6-8 weeks | $ 2,180.00 | |
100 mg | 6-8 weeks | $ 2,800.00 |
Description | RORγt Inverse agonist 8 is a potent, selective, orally bioavailable RORγt inverse agonist(human RORγt-LBD with an IC50 of 19 nM). |
Targets&IC50 | RORγt:19 nM |
In vitro | RORγt Inverse agonist 8 is a potent inhibitor of RORγt and binds to the ligand binding domain (LBD) of RORγt. RORγt Inverse agonist 8 results in complete attenuation of IL-17A secretion in a concentration-dependent manner (IC50 of 60 nM in HUT78 cells). RORγt Inverse agonist 8 selectively suppresses human Th17 and Tc17 cell differentiation. RORγt Inverse agonist 8 reduces Th17 cell-associated mRNA expression including IL17A, IL17F, IL26, IL23R and CCR6 in a concentration-dependent fashion. |
In vivo | antigen-induced arthritis (AiA) responses in Lewis rats ameliorated by RORγt Inverse agonist 8. |
Molecular Weight | 475.59 |
Formula | C26H33N7O2 |
CAS No. | 2079892-79-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
RORγt Inverse agonist 8 2079892-79-6 Metabolism ROR RORrt Inverse agonist 8 RORgammat Inverse agonist 8 inhibitor inhibit